Zelgen(SH:688266) Sou Hu Cai Jing·2025-08-23 00:16Core Viewpoint - Zai Jian Pharmaceutical (688266.SH) reported its semi-annual results for 2025, highlighting significant institutional investor interest and changes in public fund holdings [1][2]. Group 1: Institutional Holdings - As of August 22, 2025, 189 institutional investors disclosed holdings in Zai Jian Pharmaceutical, totaling 94.5062 million shares, which represents 35.70% of the company's total share capital [1]. - The top ten institutional investors collectively hold 19.74% of the shares, with a decrease of 3.08 percentage points compared to the previous quarter [1]. Group 2: Public Fund Holdings - In the current period, 40 public funds increased their holdings, with a total increase rate of 2.65%, including funds like China Europe Medical Health Mixed A and Longcheng Medical Industry Selected Mixed Initiated A [2]. - Conversely, 76 public funds reduced their holdings, with a decrease rate of 3.34%, including funds such as GF Medical Health Stock A and Ping An Medical Health Mixed A [2]. - A total of 64 new public funds were disclosed this period, while 49 funds were not disclosed compared to the previous quarter [2].